Province reports 1st death related to VITT blood-clotting syndrome

Arwen~ Reported today, one month after he died from VITT from taking the “vaccine”. A little late in reporting as that would put a damper on the push for everyone getting the jab. Truth be told, we have no idea how many have died from the jab and are just labeled COVID deaths. An epidemiologist from Yale stated that according to his counterparts reporting, 60% of those currently in ICU had taken the jab. The push is now on for youth, who do not even need parental permission in Ontario. Many should be charged with crimes against humanity in what they have been complicit in concerning C-19.


Posted May 25, 2021 3:17 pm EDT

Last Updated May 25, 2021 at 3:34 pm EDTFILE – In this Monday, March 22, 2021 file photo medical staff prepares an AstraZeneca coronavirus vaccine during preparations at the vaccine center in Ebersberg near Munich, Germany. The European Commission says it has launched legal action against vaccine maker AstraZeneca for failing to respect the terms of its contract with the EU. A Commission spokesman said Monday, April 26, 2021 that the reason for the legal action was that “some terms of the contract have not been respected” and that “the company has not been in a position to come up with a reliable strategy to ensure a timely delivery of doses.” The AstraZeneca vaccine has been central to Europe’s immunization campaign, but the slow pace of deliveries has frustrated the Europeans. AstraZeneca has previously said that its contract with the EU contained vaccine delivery targets, not firm commitments.(AP Photo/Matthias Schrader, File)

Ontario has confirmed the first death related to Vaccine-Induced Thrombotic Thrombocytopenia (VITT), an extremely rare blood clotting syndrome and side effect connected to the AstraZeneca vaccine.

Associate Medical Officer of Health Dr. Barbara Yaffe says the man, in his 40s, died after receiving a first dose of the vaccine in late April.

There have been 16 reported cases of a blood clot in Ontario out of approximately 850,000 doses administered province-wide.

The risk of VITT in Canada has been estimated to be approximately 1 per 55,000 first doses, but several possible cases are still under investigation.

Ontario is no longer offering AstraZeneca as a first dose but will administer it as a second shot as the risk of developing the side effect is much lower, around 1 in 600,000.

Early data from the United Kingdom affirms that, suggesting that the risk of VITT after second doses of the AstraZeneca vaccine is likely lower than after the first doses.

The blood clotting syndrome linked to the AstraZeneca vaccine is extremely rare but can be fatal.

In mid-May, Ontario’s Chief Medical Officer of Health Dr. David Williams said the decision to no longer offer AstraZeneca as a first shot was made as the province receives larger shipments of other vaccines, such as Pfizer and Moderna.

Williams said last week that those who got their first dose of AstraZeneca between March 10 and March 19 during a pilot project at some pharmacies and doctors’ offices will be prioritized for the second dose.

Justin Bates, CEO of the Ontario Pharmacists Association, said on Tuesday that “a few” Toronto pharmacies will receive vaccine supply today with the vast majority receiving their doses on Wednesday.

Bates says pharmacists will reach out to eligible patients who can then start booking appointments as early as Wednesday and Thursday.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: